Read the bill beyond the opening price.

Assumption to set aside · The headline number is the whole bill.

Ask for a total that continues past the offer

Keep the visit, ongoing membership, medicine, tests and delivery as separate lines in a written quote. If the clinician prescribes no medicine, ask which fees you would keep paying.

The September 26, 2026 review of national online-care adverts found a common pattern: a membership charge with the drug cost added separately.

Those pages were a small advertising sample, not a Houston price survey or proof of what a patient ultimately paid.

Please show me the continuing bill and the terms for leaving.

A cash range is context, not a Houston quote

Your body makes GLP-1, a hormone that helps control hunger and blood sugar. A hormone is a chemical messenger in the body. Medicines with semaglutide (Ozempic, Wegovy) copy this hormone’s action. Tirzepatide, in Mounjaro and Zepbound, does that too.

At the September 26, 2026 price check, the drug makers’ monthly cash offers were mostly in the $149–$499 range across the products and strengths sampled.

Some higher-strength offers cost more after a late refill, and several low figures were temporary or introductory.

A month also meant different package quantities across those products, so the range is not a like-for-like comparison.

Many offer terms in that check ran only through December 31, 2026; that date calls for a new price check, not a prediction.

Ask for the exact product, form, supply period and continuing price in your own quote. A general range cannot price a different peptide.

Insurance needs the treatment reason too

Your plan’s drug list is called a formulary. Prior authorisation is its check before agreeing to pay for a prescription.

Under the Medicare rules checked on September 26, 2026, its ordinary drug benefit, Part D, excludes medicines when used for weight loss.

Under those rules, Part D may pay for another accepted medical use, such as treating type 2 diabetes. Payment still depends on your plan’s drug list and its approval of the payment request.

A temporary Medicare programme, called the GLP-1 Bridge, helps some people pay for weight-loss treatment outside ordinary Part D. Its price was $50 per monthly supply for eligible people at the September 26, 2026 check, with selected pills and injections included. The start date was July 1, 2026; the end date is December 31, 2027. The ordinary Part D exclusion for weight-loss use still applies.

Eligibility depends on age, weight in relation to height, health conditions, the kind of Medicare drug plan and earlier coverage of these medicines. For someone with type 2 diabetes, the Bridge is unavailable; their prescription must go through ordinary Part D rules. A prescription and approval of the payment request are required; ask your prescriber to check the full rules before counting on that price.

Give the insurer both the product name and the treatment reason when asking about cover. Save its reply beside the quote.

Cash pricing and a savings card have different terms

Self-pay means paying outside insurance. Under manufacturer terms checked September 26, 2026, those cash payments do not count toward your deductible: what you pay before insurance starts sharing covered costs. They also do not count toward your out-of-pocket maximum, the most your plan makes you pay yourself for covered care in a year.

A manufacturer’s copay card helps with your share of a prescription bill. Under terms checked September 26, 2026, a card is available only with private or workplace insurance. People with government health coverage, including Medicare, cannot use these cards. The manufacturer’s separate cash offer may still be open to those people.

Ask whether an offer is a cash price or a copay card before comparing the figures.

Is this the medicine price, a membership charge, an insured copay or an opening discount?

Leave the visit with something you can compare

Ask for the quote in writing, including cancellation terms and any prepaid commitment. Put another option beside it using the same supply period.

If the medicine is compounded, keep the question about its medical need alongside the cost question. A price cannot answer both.